< 1 minute read
Sep. 13, 2024
A Small Peptide Inhibitor of the Fas Receptor for IRD
ONL1204
Fas receptor inhibitor Ph. II in macula-off rhegmatogenous retinal detachment derivative of a previously reported Fas inhibitor (Met12) Cell Death Dis., August 2024 ONL Therapeutics, Ann Arbor, MI
Other molecules you may be interested in
compound 59
The Dompé Farmaceutici TRPM8 blocker, compound 59 is a potent (IC50 = 11 nM) compound for painful ocular conditions, with ocular efficacy in a preclinical behavioral model. TRPM8 is a cation channel which is the predominant in mammalian cold thermosensor and it is activated by well-known molecules like menthol, eucalyptol, and geraniol [...]